Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CTR20262373 KH-607 Depressive Disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262373 clinical trial report covering KH-607, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07677878 Blinatumomab Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677878 clinical trial report covering Blinatumomab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262540 SYH2053 Renal Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262540 clinical trial report covering SYH2053, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07677917 Dexmedetomidine Hydrochloride Agitation Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07677917 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 1, endpoints, sponsor, geography, readout timing and development white spac
Read →
Latest Hotspot
8 min read
CTR20262459 Group B meningitis vaccine(Delonix Bioworks) Meningitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262459 clinical trial report covering Group B meningitis vaccine(Delonix Bioworks), Phase 1, endpoints, sponsor, geography, readout timing and develop
Read →
Latest Hotspot
8 min read
CTR20262469 Tinengotinib Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262469 clinical trial report covering Tinengotinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07679919 LMY-922 Hairy Cell Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07679919 clinical trial report covering LMY-922, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07679334 Pacritinib Polycythemia Vera Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07679334 clinical trial report covering Pacritinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262505 NTQ5082 Hemoglobinuria, Paroxysmal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262505 clinical trial report covering NTQ5082, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262423 Alpha-0261 Chronic Urticaria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262423 clinical trial report covering Alpha-0261, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20262530 Girocitinib Urticaria Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
CTR20262530 clinical trial report covering Girocitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07681479 HRS-9057 Body fluid retention Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
4 August 2026
NCT07681479 clinical trial report covering HRS-9057, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
994
995
996
997
998
>>
2260
>